Portal chronic inflammation (CI) in nonalcoholic fatty liver disease (NAFLD): Correlations from the NASH clinical research network (CRN)

被引：0
|
作者：
Brunt, E. M. [1 ]
Kleiner, D. E. [1 ]
Wilson, L. [1 ]
机构：
[1] CRN, NASH, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1371
引用
收藏
页码：301A / 301A
页数：1
相关论文
共 50 条
  • [1] Portal chronic inflammation (CI) in nonalcoholic fatty liver disease (NAFLD): Correlations from the NASH clinical research network (CRN)
    Brunt, E. M.
    Kleiner, D. E.
    LABORATORY INVESTIGATION, 2008, 88 : 301A - 301A
  • [2] Portal Chronic Inflammation in Nonalcoholic Fatty Liver Disease (NAFLD): A Histologic Marker of Advanced NAFLD-Clinicopathologic Correlations from the Nonalcoholic Steatohepatitis Clinical Research Network
    Brunt, Elizabeth M.
    Kleiner, David E.
    Wilson, Laura A.
    Unalp, Aynur
    Behling, Cynthia E.
    Lavine, Joel F.
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2009, 49 (03) : 809 - 820
  • [3] Portal inflammation in NAFLD: Correlations from the NASH CRN database
    Brunt, Elizabeth M.
    Kleiner, David E.
    Behling, Cynthia
    Wilson, Laura
    Lavine, Joel E.
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2006, 44 (04) : 644A - 644A
  • [4] Natural history of nonalcoholic fatty liver disease (NAFLD) in children receiving standard lifestyle counseling and placebo in NASH Clinical Research Network (CRN) trials
    Xanthakos, Stavra
    Lavine, Joel E.
    Yates, Katherine P.
    Schwimmer, Jeffrey B.
    Molleston, Jean P.
    Rosenthal, Philip
    Murray, Karen F.
    Vos, Miriam B.
    Jain, Ajay
    Fishbein, Mark
    Behling, Cynthia A.
    Brunt, Elizabeth M.
    Tonascia, James
    Doo, Edward
    HEPATOLOGY, 2017, 66 : 31A - 32A
  • [5] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [6] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [7] Pediatric Nonalcoholic Fatty Liver Disease (NAFLD): Histological Feature Changes Over Time in Paired Biopsies from the NASH CRN
    Brunt, Elizabeth M.
    Kleiner, David E.
    Belt, Patricia H.
    Molleston, Jean P.
    Schwimmer, Jeffrey B.
    Lavine, Joel E.
    Neuschwander-Tetri, Brent A.
    HEPATOLOGY, 2014, 60 : 290A - 290A
  • [8] Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Drescher, Hannah K.
    Weiskirchen, Sabine
    Weiskirchen, Ralf
    CELLS, 2019, 8 (08)
  • [9] Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Gerhardt, Florian
    Petroff, David
    Blank, Valentin
    Boehlig, Albrecht
    van Boemmel, Florian
    Wittekind, Christian
    Berg, Thomas
    Karlas, Thomas
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 706 - 711
  • [10] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
12345